For over 30 years, PAREXEL has proven to be a trusted partner for the complex development journey required of biopharmaceutical and medical device companies. We're also an astute guide, able to simplify that journey for our clients, so safe new products can reach patients more quickly.
Headquartered near Boston, Massachusetts, PAREXEL International operates in 76 locations with more than 15,000 employees in 50 countries worldwide. We provide the most comprehensive drug development capabilities of any CRO worldwide.
Our global regulatory expertise, Phase I-IV clinical research services, integrated eClinical technologies, and advanced commercialization services all work together to move our clients through the development journey more smoothly and cost-effectively from beginning to end.